viagra india livraison rapide cialis cialis rezeptfrei usa viagra sur le net cialis se vende sin receta cialis senza ricetta svizzera http://msh.univ-tours.fr/site_genre/wp-a... acheter viagra generique acheter viagra pharmacie http://philosophie.ac-creteil.fr/?hostur... http://philosophie.ac-creteil.fr/?hostur... http://philosophie.ac-creteil.fr/?hostur... cialis a vendre montreal viagra achat en france levitra belge acheter viagra et cialis en ligne acquisto tadalafil köpa viagra online http://science.upm.edu.my/fsc2013/plugin... kamagra ajanta pharma pharmacy cialis

Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study

Tue, Sep 20, 2011

Oral Cancer News

Source: RedJournal.org

Purpose

The aim of this pharmaco-epidemiological study was to evaluate the prevalence of oropharyngeal candidiasis (OPC) in cancer patients treated with chemotherapy and/or radiotherapy.

Methods and Materials

Signs and symptoms of OPC were noted for all patients. Antifungal therapeutic management was recorded in OPC patients. Patients receiving local antifungal treatments were monitored until the end of treatment.

Results

Enrolled in the study were 2,042 patients with solid tumor and/or lymphoma treated with chemotherapy and/or another systemic cancer treatment and/or radiotherapy. The overall prevalence of OPC was 9.6% (95% confidence interval, 8.4%–11.0%] in this population. It was most frequent in patients treated with combined chemoradiotherapy (22.0%) or with more than two cytotoxic agents (16.9%). Local antifungal treatments were prescribed in 75.0% of OPC patients as recommended by guidelines. The compliance to treatment was higher in patients receiving once-daily miconazole mucoadhesive buccal tablet (MBT; 88.2%) than in those treated with several daily mouthwashes of amphotericin B (40%) or nystatin (18.8%).

Conclusion

OPC prevalence in treated cancer patients was high. Local treatments were usually prescribed as per guidelines. Compliance to local treatments was better with once-daily drugs.

This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

Print Friendly
Be Sociable, Share!
, , , , ,

Leave a Reply

You must be logged in to post a comment.